Form4insider filings, from the source

SEC Form 4 · accession 0001535610-19-000067

ReShape Lifesciences Inc. · RSLS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 31, 2019
Accepted (ET)
Feb 4, 2019 · 1:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 31, 2019P10,301$0.2733A1,192,507ISee Footnotes
Common StockF3,F1,F2Feb 1, 2019P$01,192,000—D507ISee Footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series E Convertible Preferred StockF3,F1,F2—Feb 1, 2019J1,192,000AFeb 1, 2019Feb 1, 2039Common Stock1,192,0001,192,000I

Explanation of responses